ModernaTX Inc.,* Cambridge, Massachusetts, was awarded a $3,300,000,000 modification (P00007) to contract W911QY-20-C-0100 for 200 million filled drug production doses of SARS-CoV-2 mRNA-1273 Moderna vaccine. Work will be performed in Cambridge, Massachusetts, with an estimated completion date of March 31, 2022. Fiscal 2010 research, development, test and evaluation (Army) funds in the amount of $3,300,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded June 15, 2021)
free preview